EHREN GLECKLER: Open Payments
NPI 1164958484 · AUBURN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,089 in 62 payments from 13 companies in 2025. Trend: 2023 $1,286 · 2024 $1,114 · 2025 $1,089
Food & beverage: $1,089
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $317 |
| Novo Nordisk Inc | 14 | $177 |
| AstraZeneca Pharmaceuticals LP | 6 | $119 |
| Amgen Inc. | 7 | $110 |
| Vanda Pharmaceuticals Inc. | 5 | $110 |
| PFIZER INC. | 5 | $92 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
| Exact Sciences Corporation | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: VRAYLAR, Ozempic, OTEZLA, NURTEC ODT, BREZTRI, HETLIOZ, FANAPT, Wegovy.
Industry payments across GA — which companies pay providers there.
